Annual report pursuant to Section 13 and 15(d)

Income Taxes (Tables)

v3.24.0.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2023
Income Taxes  
Components Of Consolidated (Loss) Income From Continuing Operations Before Income Taxes

Year Ended December 31,

2023

2022

2021

U.S. operations

$

(19,929)

$

(24,318)

$

(14,043)

Foreign operations

(150)

(83,200)

(3,068)

Loss from continuing operations before income tax

$

(20,079)

$

(107,518)

$

(17,111)

Components Of Benefit For Income Taxes

Year Ended December 31,

2023

2022

2021

Current:

Federal

$

-

$

-

$

(6,064)

State and local

90

150

(162)

Foreign

833

1,575

2,057

923

1,725

(4,169)

Deferred:

Federal

(4,972)

(1,338)

4,453

State and local

2,909

604

472

Foreign

(542)

(14,652)

(2,020)

(2,605)

(15,386)

2,905

Change in valuation allowance for deferred income taxes

(2,609)

(1,055)

(17,970)

(5,214)

(16,441)

(15,065)

Income tax benefit

$

(4,291)

$

(14,716)

$

(19,234)

Year Ended December 31,

2023

2022

2021

Continuing operations

$

(4,291)

$

(14,716)

$

(19,234)

Discontinued operations

2,024

7,365

7,020

$

(2,267)

$

(7,351)

$

(12,214)

Schedule Of Effective Income Tax Rate Reconciliation

Year Ended December 31,

2023

2022

2021

Statutory income tax (benefit) expense

(21.0)

%

(21.0)

%

(21.0)

%

Increase (decrease) in income taxes resulting from:

Foreign taxes

0.6

(3.5)

1.0

State income taxes, net of federal income taxes

(1.9)

1.0

3.7

Income tax credits

(6.6)

(1.3)

(6.3)

Stock options

1.2

(0.9)

(4.5)

Change in effective state rate

-

0.1

0.2

Deferred tax asset write-offs

13.0

-

-

Executive compensation limitation

4.4

2.2

5.9

Change in valuation allowance

(13.0)

(1.0)

(105.0)

Impairment of goodwill

-

10.3

-

Research and development expenditure

1.9

0.4

1.4

Fair value inventory step-up

-

-

3.9

Transaction costs

-

-

8.3

Income tax (benefit) expense

(21.4)

%

(13.7)

%

(112.4)

%

Schedule Of Deferred Tax Assets And Liabilities

December 31,

2023

2022

Deferred tax assets:

Net operating loss, capital loss and research & experimentation credit carryforwards

$

6,752

$

10,685

Capitalized research and development costs

8,937

8,205

Capitalized costs to self-constructed property

10,593

7,892

Non-cash compensation

2,360

2,534

Accrued liabilities

1,655

1,472

Reserves and other

4,624

1,960

Lease liabilities

3,902

-

Intangibles

1,070

224

39,893

32,972

Valuation allowance

(714)

(3,323)

Net deferred tax assets

39,179

29,649

Deferred tax liabilities:

Depreciation

(1,712)

(1,390)

Intangibles

(28,470)

(28,319)

Right-of-use assets

(3,647)

-

Other

(605)

(534)

(34,434)

(30,243)

Total

$

4,745

$

(594)

Schedule Of Roll Forward Of Valuation Allowance For Deferred Income Tax Assets

Balance at Beginning of Year

Charged to Costs and Expenses

Other Adjustments

Balance at End of Year

2021

$

22,348

$

(17,970)

$

-

$

4,378

2022

$

4,378

$

51

$

(1,106)

$

3,323

2023

$

3,323

$

26

$

(2,635)

$

714

Summary Of Tax Credit Carryforwards

Net Operating Loss Carryforward Expiration Dates

December 31, 2023

Expiration Dates December 31,

    

Net Operating Loss Amount

2024

$

-

2025

-

2026

-

2027 and beyond

7,699

Total

$

7,699

Schedule Of Unrecognized Tax Benefits

December 31,

2023

2022

2021

Balance, beginning of year

$

813

$

696

$

427

Additions for current year tax positions

98

159

143

Additions for prior year tax positions

8

-

237

Reductions for prior year tax positions

-

(42)

(111)

Reductions due to statute expirations

(29)

-

-

Balance, end of year

$

890

$

813

$

696